Pair Name | Tannic acid, Cisplatin | ||
Phytochemical Name | Tannic acid (PubChem CID: 16129778 ) | ||
Anticancer drug Name | Cisplatin (PubChem CID: 5702198 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Tannic acid, Cisplatin | |||
Disease Info | [ICD-11: 2C12] | Hepatocellular carcinoma | Investigative | |
Biological Phenomena | Induction-->Mitochondria-mediated apoptosis | |||
Gene Regulation | Up-regulation | Expression | BAX | hsa581 |
Down-regulation | Expression | BCL2 | hsa596 | |
Up-regulation | Cleavage | CASP3 | hsa836 | |
Up-regulation | Expression | CYCS | hsa54205 | |
In Vitro Model | Hep-G2 | Hepatoblastoma | Homo sapiens (Human) | CVCL_0027 |
Result | The results obtained from the present study suggest that the combination of TA and CDDP may exert synergistic anticancer effects and may be a novel adjuvant treatment for liver cancer. |
Pair Name | Tannic acid, Cisplatin | |||
Disease Info | [ICD-11: 2C25] | Lung cancer | Investigative | |
Biological Phenomena | Induction-->Endoplasmic reticulum stress | |||
Gene Regulation | Up-regulation | Expression | ATF4 | hsa468 |
Up-regulation | Expression | ATF6 | hsa22926 | |
Up-regulation | Cleavage | CASP3 | hsa836 | |
Up-regulation | Expression | DDIT3 | hsa1649 | |
Up-regulation | Expression | EIF2AK3 | hsa9451 | |
Up-regulation | Expression | EIF2S1 | hsa1965 | |
Up-regulation | Expression | HSPA5 | hsa3309 | |
In Vitro Model | NCI-H1299 | Lung large cell carcinoma | Homo sapiens (Human) | CVCL_0060 |
GLC-82 | Human papillomavirus-related cervical adenocarcinoma | Homo sapiens (Human) | CVCL_3371 | |
In Vivo Model | Cells (1×10⁷) were suspended in 200 µL 0.9% saline and injected subcutaneously into the axilla of 6-week-old mice for 7 d. | |||
Result | The combination of TA and CDDP may produce synergistic antitumoral effects mediated by the PERK-ATF4-CHOP apoptotic axis, suggesting a novel adjuvant treatment for lung cancer. |
Pair Name | Tannic acid, Cisplatin | |||
Disease Info | [ICD-11: 2C25] | Lung cancer | Investigative | |
Biological Phenomena | Induction-->Endoplasmic reticulum stress | |||
In Vitro Model | A-549 | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_0023 |
RAW 264.7 | Leukemia | Mus musculus (Mouse) | CVCL_0493 | |
In Vivo Model | Mice were subcutaneously inoculated with LLC cells (1×10⁶/mouse) in 0.1 ml of PBS at the armpit of the foreleg. | |||
Result | Tannins in Phyllanthus emblica L. improves cisplatin efficacy in lung cancer cells by boosting endoplasmic reticulum stress to trigger immunogenic cell death |
No. | Title | Href |
---|---|---|
1 | Tannic acid synergistically enhances the anticancer efficacy of cisplatin on liver cancer cells through mitochondria‑mediated apoptosis. Oncol Rep. 2019 Nov;42(5):2108-2116. doi: 10.3892/or.2019.7281. | Click |
2 | Synergistic anticancer activity of cisplatin combined with tannic acid enhances apoptosis in lung cancer through the PERK-ATF4 pathway. Eur J Med Res. 2023 Oct 27;28(1):462. doi: 10.1186/s40001-023-01420-z. | Click |
3 | Tannins in Phyllanthus emblica L. improves cisplatin efficacy in lung cancer cells by boosting endoplasmic reticulum stress to trigger immunogenic cell death. Phytomedicine. 2024 Jan;123:155219. doi: 10.1016/j.phymed.2023.155219. | Click |